Last updated on March 2020

A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis


Brief description of study

The purpose of this study is to evaluate the long-term safety and efficacy of baricitinib in participants with atopic dermatitis.

Clinical Study Identifier: NCT03334435

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.